89Zr-JRF/AbetaN/25

N/A

Report date: 2025/01/26 19:27:52

Base Information

Drug Name89Zr-JRF/AbetaN/25
Drug Alias Namebeta amyloid PET imaging agent (Janssen Pharmaceutica)
ClassificationOther
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJanssen Pharmaceutica NV
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Pharmaceutica NV
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A